title: Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.
abstract: Sepiapterin reductase (SPR) gene is an enzyme which catalyses the final step of tetrahydrobiopterin synthesis (BH4) and was implicated in Parkinson's disease (PD) pathogenesis as a candidate gene for PARK3 locus. A number of studies yielded association of the PARK3 locus with PD, and SPR knockout mice were shown to display parkinsonian features. To evaluate the role of SPR gene polymorphisms in diverse populations in PD, we performed collaborative analyses in the Genetic Epidemiology of Parkinson Disease (GEO-PD) Consortium. A total of 5 single nucleotide polymorphisms (3 in the promoter region and 2 in the 3' untranslated region [UTR]) were genotyped. Fixed as well as random effect models were used to provide summary risk estimates of SPR variants. A total of 19 sites provided data for 6547 cases and 9321 controls. Overall odds ratio estimates varied from 0.92 to 1.01. No overall association with the SPR gene using either fixed effect or random effect model was observed in the studied population. I(2) Metric varied from 0% to 36.2%. There was some evidence for an association for participants of North European/Scandinavian descent with the strongest signal for rs1876487 (odds ratio = 0.82; p value = 0.003). Interestingly, families which were used to map the PARK3 locus, have Scandinavian ancestry suggesting a founder effect. In conclusion, this large association study for the SPR gene revealed no association for PD worldwide. However, taking the initial mapping of the PARK3 into account, the role of a population-specific effect warrants consideration in future studies.
authors.affiliation: Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tuebingen, Germany. manu.sharma@uni-tuebingen.de
authors.forename: Manu
authors.initials: M
authors.lastname: Sharma
authors.forename: Demetrius M
authors.initials: DM
authors.lastname: Maraganore
authors.forename: John P A
authors.initials: JP
authors.lastname: Ioannidis
authors.forename: Olaf
authors.initials: O
authors.lastname: Riess
authors.forename: Jan O
authors.initials: JO
authors.lastname: Aasly
authors.forename: Grazia
authors.initials: G
authors.lastname: Annesi
authors.forename: Nadine
authors.initials: N
authors.lastname: Abahuni
authors.forename: Anna Rita
authors.initials: AR
authors.lastname: Bentivoglio
authors.forename: Alexis
authors.initials: A
authors.lastname: Brice
authors.forename: Christine
authors.initials: C
authors.lastname: Van Broeckhoven
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Chartier-Harlin
authors.forename: Alain
authors.initials: A
authors.lastname: Destée
authors.forename: Ana
authors.initials: A
authors.lastname: Djarmati
authors.forename: Alexis
authors.initials: A
authors.lastname: Elbaz
authors.forename: Matthew
authors.initials: M
authors.lastname: Farrer
authors.forename: Carlo
authors.initials: C
authors.lastname: Ferrarese
authors.forename: J Mark
authors.initials: JM
authors.lastname: Gibson
authors.forename: Suzana
authors.initials: S
authors.lastname: Gispert
authors.forename: Nobutaka
authors.initials: N
authors.lastname: Hattori
authors.forename: Barbara
authors.initials: B
authors.lastname: Jasinska-Myga
authors.forename: Christine
authors.initials: C
authors.lastname: Klein
authors.forename: Suzanne
authors.initials: S
authors.lastname: Lesage
authors.forename: Timothy
authors.initials: T
authors.lastname: Lynch
authors.forename: Peter
authors.initials: P
authors.lastname: Lichtner
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Lambert
authors.forename: Anthony E
authors.initials: AE
authors.lastname: Lang
authors.forename: George D
authors.initials: GD
authors.lastname: Mellick
authors.forename: Francesa
authors.initials: F
authors.lastname: De Nigris
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Opala
authors.forename: Aldo
authors.initials: A
authors.lastname: Quattrone
authors.forename: Chiara
authors.initials: C
authors.lastname: Riva
authors.forename: Ekaterina
authors.initials: E
authors.lastname: Rogaeva
authors.forename: Owen A
authors.initials: OA
authors.lastname: Ross
authors.forename: Wataru
authors.initials: W
authors.lastname: Satake
authors.forename: Peter A
authors.initials: PA
authors.lastname: Silburn
authors.forename: Jessie
authors.initials: J
authors.lastname: Theuns
authors.forename: Tatsushi
authors.initials: T
authors.lastname: Toda
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tomiyama
authors.forename: Ryan J
authors.initials: RJ
authors.lastname: Uitti
authors.forename: Karin
authors.initials: K
authors.lastname: Wirdefeldt
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Wszolek
authors.forename: Thomas
authors.initials: T
authors.lastname: Gasser
authors.forename: Rejko
authors.initials: R
authors.lastname: Krüger
mesh_terms: D000429:Alcohol Oxidoreductases / Q000235:genetics*; D056726:Genetic Association Studies; D056426:Genetic Loci / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D010300:Parkinson Disease / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic
chemical_list: D000429:Alcohol Oxidoreductases; C022630:sepiapterin reductase